Phase 3 Bladder Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been diagnosed with advanced bladder or urinary tract cancer that has been confirmed by a lab test (biopsy).
• You are able to receive a type of chemotherapy that contains platinum (such as cisplatin or carboplatin).
• You have previously been treated with a type of immunotherapy drug called an anti-PD-(L)1 therapy (for example, pembrolizumab or atezolizumab) for advanced or spreading cancer.
• If your immunotherapy was given around the time of surgery, your cancer must have come back within 12 months of your last dose.
• You have at least one area of cancer that can be measured on a scan.
• You are generally well enough to carry out light activity and care for yourself (confirm with trial site for exact fitness level required).

Who may not be able to join:

• You have received platinum-based chemotherapy within the last 12 months.
• You have already had more than 2 different cancer treatment regimens in total.
• You have previously received a type of targeted drug therapy (called an ADC) that targets EGFR or HER3.
• You have previously been treated with a drug that belongs to a group called topoisomerase 1 inhibitors (confirm with trial site for specific examples).
• You currently have cancer that has spread to the brain and is not being treated.
• There are additional criteria set by the trial team that may also affect eligibility (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.